Moleculin Biotech Inc.

09/23/2026 | Press release | Distributed by Public on 09/23/2026 06:31

Moleculin Biotech Secures Mexican Patent Protecting Lung-Targeted Liposomal Annamycin Through 2040

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Moleculin Biotech Inc. published this content on September 23, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 23, 2026 at 12:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]